Stay updated on Parpvax: Niraparib + Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.

Latest updates to the Parpvax: Niraparib + Immunotherapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision banner shows Revision: v3.4.2, and the government funding status notice has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide lapse-in-funding notice about NIH Clinical Center operations with links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0 revision.SummaryDifference0.4%

- Check28 days agoChange DetectedA new 'Show glossary' option appears on the Study Details page, and several small metadata/text updates were made (including Last Update Posted, capitalization in Last Update Submitted that Met QC Criteria, capitalization in No FEAR Act data, and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no other changes to core content or trial details were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new Locations section listing Pennsylvania as a study site. The HHS Vulnerability Disclosure link in the footer was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page (likely in header or footer). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Parpvax: Niraparib + Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.